← Back to Clinical Trials
Recruiting NCT06423014

NCT06423014 Smart mHealth Strategy for Physical Activity and Health Promotion

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06423014
Status Recruiting
Phase
Sponsor Taipei Medical University
Condition Health Behavior Change
Study Type INTERVENTIONAL
Enrollment 360 participants
Start Date 2023-05-01
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Wearable devices onlyWearable devices with the 1st behavior change techniqueWearable devices with the 2nd behavior change technique

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 360 participants in total. It began in 2023-05-01 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to develop a Smart mHealth Strategy that delivers behavior change techniques through wearable physical activity trackers and social media chatbots, including self-monitoring, real-time feedback and reminders, goal-setting, competition and rewards, social support, and health coaching. This study also aims to explore the effect of the Smart mHealth Strategy on the behavioral outcomes and psychological factors of physical activity, and physical and mental health. The study design is a three-stage randomized controlled trial. In each stage, 120 are recruited and randomly assigned to control and experimental groups. Participants are adults with insufficient physical activity and a sedentary lifestyle. The Smart mHealth Strategy uses smartwatches and self-developed chatbots. The constrained dialogue content is designed to finally deliver the six behavior change techniques. Data are collected in the pre-, mid-, and post-tests. The measurement includes self-administered questionnaires, Actigraphy GT9X, Inbody 270S, OMRON HEM-7130, and heart rate variability monitors.

Eligibility Criteria

Inclusion Criteria: Adults who is the age of majority, with insufficient physical activity, and a sedentary lifestyle who have smartphones Exclusion Criteria: * Individuals' health conditions may affect physical activity in daily living and the experiment, such as disability, serious health problems * There are unconventional life plans during the experiment, such as going abroad for vacation, pregnancy, and surgery. * Individuals have using experiences in any wearable physical activity trackers in the past six months ④ People who have ever had severe allergies to any wearable device ⑤ Professional athletes or student-athletes

Contact & Investigator

Central Contact

Hsin-Yen Yen, PhD

✉ kenji@tmu.edu.tw

📞 886-2-2736-1661

Frequently Asked Questions

Who can join the NCT06423014 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Health Behavior Change. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06423014 currently recruiting?

Yes, NCT06423014 is actively recruiting participants. Contact the research team at kenji@tmu.edu.tw for enrollment information.

Where is the NCT06423014 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT06423014 clinical trial?

NCT06423014 is sponsored by Taipei Medical University. The trial plans to enroll 360 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology